You are here: Home / Protocols


EDRN investigators protocols. The following is a list of the EDRN protocols that have been captured and curated. Additional information will be added as it is available. Contact information is provided as part of the detail for each protocol.


Title Abstract Investigator
A Biomarker Bakeoff in Early Stage Pancreatic Cancer Previous research in EDRN laboratories and elsewhere has produced several candidate biomarker(s) for the detection of early-stage pancreatic ductal ... Brand (BDL), Randall
A Methylation Panel for Bladder Cancer Participate in a prevalidation study for methylation based detection of bladder cancer. In addition, a panel of three markers identified will be evaluated for ... Gazdar, Adi
A Prospective Study to Establish a New Onset Diabetes (NOD) Cohort Chari, Suresh
Affinity-based strategies to fast track development of colon cancer biomarkers Our goal is to discover plasma and tissue-based tumor biomarkers that work well enough together to identity colon cancer at early stages, lead to accurate ... Lampe, Paul
An Automated System for Breast Cancer Biomarker Analysis To normalize FFDM data by accounting for varying image acquisition parameters and settings. Heine, John
Antibodies Against Tumor Antigens or Mucin Epitopes in Ovarian Cancer Cramer, Daniel
Assessment of Clinical Potential of Digital SNP Analysis Helzlsouer, Kathy
Aurora Kinase A as a Biomarker for the Detection of Bladder Cancer - Supplemental Pre-Validation Protocol Czerniak, Bogdan
Autoantibody Approach for Serum-Based Detection of Head and Neck Cancer Our long term goal is to improve survival of patients with head and neck squamous cell carcinoma (HNSCC) through early detection using simple noninvasive serum ... Tainsky, Michael A.
Automated Quantitative Measures of Breast Density Mammographic breast density (BD) is a significant breast cancer risk factor, second in magnitude only to inherited BRCA mutations. Most research studies ... Heine, John
BBD Reference Set Application: Jeffery Marks-Duke (2015) We propose a pre-validation study for markers that could predict the likelihood of invasive breast cancer following a tissue diagnosis of benign breast ... Marks, Jeffrey
BRSCW Reference Set Application: Anna Lokshin - Univ of Pitts (2008) Validate biomarkers identified using Luminex bead-based arrays in case/control sets (individual samples) in reference sets Lokshin, Anna
BRSCW Reference Set Application: Anu Mathew - Meso Scale (2006) 46 markers were tested on pooled case samples and on control samples. Mathew, Anu
BRSCW Reference Set Application: Eleftherios Diamandis - Mt Sinai (2006) Examine kallikreins as ovarian cancer biomarkers Diamandis, Eleftherios P.
BRSCW Reference Set Application: GeorgeTuszynski - Temple University (2012) The marker GASP-1 was evaluated in the pooled breast cancer reference set. It did not seem to be elevated relative to controls. Tuszynski, George
BRSCW Reference Set Application: James Morre - NOX Technologies Inc. (2009) Evaluation using NOX Technologies ECTO-NOX blot diagnostic 2-D gel electrophoretic cancer detection system in combination with a sandwich ELISA of our ... Morre, D. James
BRSCW Reference Set Application: Joe Buechler - Biosite Inc (2009) Over 40 marker assays are available to run on the samples. These include markers such as Osteopontin, Mesothelin, Periostin, Endoglin, intestinal Fatty Acid ... Buechler, Joe
BRSCW Reference Set Application: Karen Abbott -University of Arkansas (2014) Our earlier glycoproteomic studies have identified bisecting glycoslyation and core fucosylation changes on particular glycoproteins in endometrioid ovarian ... Abbott, Karen
BRSCW Reference Set Application: Michael Birrer-Massachusetts General Hospital (2013) Validate FGF18 and GPR172A in reference set Birrer, Michael
BRSCW Reference Set Application: Michael Wilson - EIC Laboratories, Inc (2007) The selected markers are well established as "standard" markers fo ra range of cancers, and have been analyzed in the reference set as a benchmark for ... Wilson, Michael S.
Barrett's Esophagus Methylation Profiles We propose a nested case-control study of biomarkers in the setting of BE. By bringing together research institutions with large populations of patients with ... Meltzer, Stephen
Benign Breast Disease Team Project To identify women diagnosed with atypical ductal hyperplasia (ADH) who are at increased risk of developing invasive breast cancer (IBC) and who might benefit ... Engstrom, Paul
Biomarker Detection Using NAPPA Tumor Antigen Arrays The overall goal of this project is to identify autoantibody biomarkers in sera that can be readily used for the early detection of cancers LaBaer, Joshua
Biomarker Detection Using NAPPA Tumor Antigen Arrays: EDRN Supplement The overall goal of this project application for the EDRN set-aside funds is to focus our collaborative efforts to identify p53 mutation-specific antibody ... Anderson, Karen
Biomarker Dev Lab At Moffitt Supplement Tockman, Melvyn S.
Biomarker Development Laboratory Zhao, Yingming
Biomarker Discovery for Renal Cell Carcinoma Through Serum, Urine and Tissue Protein Profiles Basler, Joseph W.
Biomarker Reference Sets for Cancers in Women The purpose of this study is to develop a standard reference set of specimens for use by investigators participating in the National Cancer Institutes Early ... Cramer, Daniel
Biomarkers for Early Detection of Clinically Relvant Prostate Cancer: A Multi-Institutional Validation Trial - Genomic Health, Inc. Validate a panel of tissue-based biomarkers to determine the presence of or progression to clinically relevant prostate cancer at the time of diagnosis. ... Lin UW, Daniel W.
Biomarkers for Prostate and Bladder Cancer CD26+ cancer cells and CD90+ tumor-associated stromal cells were sorted from tumor tissue. Dataset analysis with transcriptomes of CD26+ luminal, CD104+ basal, ... Liu, Alvin Y.
🔜 Data-Sci Workshop
The EDRN Biomarker Data Science Workshop is coming this August, 2020. More details available soon.
Announcement 03/17/2020

The EDRN Registration page will be available soon to register for the 35th EDRN Steering Committee Meeting, now scheduled to take place from June 30-July 2, 2020, in Tempe, AZ.

This icon signifies that something is happening and we kindly ask you to please wait